Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17643583 | 0.89 | POLB (0.34) | POLBGAAMAPTHPGDRAB9A | |
| SCHEMBL18376106 | 0.89 | POLB (0.31) | POLBGAAMAPTHPGDRAB9A | |
| SCHEMBL16603173 | 0.82 | MAOA (0.36) | HPGDALDH1A1MAOAMAOB | |
| SCHEMBL17518763 | 0.81 | ATM (0.35) | MAPTHPGDRAB9AALDH1A1CYP3A4 | |
| SCHEMBL16603298 | 0.81 | MTNR1A (0.31) | — | |
| SCHEMBL17518764 | 0.77 | MAPT (0.34) | MAPTHPGDALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL18376077 | 0.75 | CES1 (0.35) | MAPTHPGDRAB9AALDH1A1CYP3A4 | |
| SCHEMBL17518762 | 0.75 | ATM (0.33) | MAOAMAOB | |
| SCHEMBL16627960 | 0.74 | MAPT (0.33) | MAPTHPGDALDH1A1 | |
| SCHEMBL24621395 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170012223-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-01-12 | — | — | US | disclosed |
| US-20160260913-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170012223-A1 | Organic Electroluminescent Materials and Devices | EML4, MT-ND4L, MT-ND4 | POLB 1211/4885GAA 2890/4885MAPT 1244/4885 |
| US-20160260913-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | EML4, TYR, L1CAM | POLB 898/4885GAA 2478/4885MAPT 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.